| Dexamethasone | Approved Investigational Vet Approved | AQP3 | 360 |
upregulated | Dexamethasone results in increased expression of AQP3 mRNA | 9p13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | AQP7 | 364 |
upregulated | Dexamethasone results in increased expression of AQP7 mRNA | 9p13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | AQP7P1 | 375719 |
upregulated | Dexamethasone results in increased expression of AQP7P1 mRNA | 9q13 | |
| Dexamethasone | Approved Investigational Vet Approved | AR | 367 |
downregulated | Dexamethasone results in decreased expression of AR mRNA | Xq12 | |
| Dexamethasone | Approved Investigational Vet Approved | ARHGAP20 | 57569 |
upregulated | Dexamethasone results in increased expression of ARHGAP20 mRNA | 11q22.3-q23.1 | |
| Dexamethasone | Approved Investigational Vet Approved | ARHGAP22 | 58504 |
downregulated | Dexamethasone results in decreased expression of ARHGAP22 mRNA | 10q11.22-q11.23 | |
| Dexamethasone | Approved Investigational Vet Approved | ARHGAP6 | 395 |
upregulated | Dexamethasone results in increased expression of ARHGAP6 mRNA | Xp22.2 | |
| Dexamethasone | Approved Investigational Vet Approved | ASB1 | 51665 |
downregulated | Dexamethasone results in decreased expression of ASB1 mRNA | 2q37.3 | |
| Dexamethasone | Approved Investigational Vet Approved | ASNS | 440 |
downregulated | Dexamethasone results in decreased expression of ASNS mRNA | 7q21.3 | |
| Dexamethasone | Approved Investigational Vet Approved | ASPA | 443 |
upregulated | Dexamethasone results in increased expression of ASPA mRNA | 17p13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | ASS1 | 445 |
upregulated | Dexamethasone results in increased expression of ASS1 mRNA | 9q34.11 | |
| Dexamethasone | Approved Investigational Vet Approved | ATF5 | 22809 |
downregulated | Dexamethasone results in decreased expression of ATF5 mRNA | 19q13.33 | |
| Dexamethasone | Approved Investigational Vet Approved | ATP1B3 | 483 |
upregulated | Dexamethasone results in increased expression of ATP1B3 mRNA | 3q23 | |
| Dexamethasone | Approved Investigational Vet Approved | ATP2B4 | 493 |
upregulated | Dexamethasone results in increased expression of ATP2B4 mRNA | 1q32.1 | |
| Dexamethasone | Approved Investigational Vet Approved | ATP5A1 | 498 |
upregulated | Dexamethasone results in increased expression of ATP5A1 mRNA | 18q21.1 | |
| Dexamethasone | Approved Investigational Vet Approved | ATP6AP2 | 10159 |
downregulated | Dexamethasone results in decreased expression of ATP6AP2 mRNA | Xp11.4 | |
| Dexamethasone | Approved Investigational Vet Approved | AZGP1 | 563 |
upregulated | Dexamethasone results in increased expression of AZGP1 mRNA | 7q22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | AZIN2 | 113451 |
downregulated | Dexamethasone results in decreased expression of AZIN2 mRNA | 1p35.1 | |
| Dexamethasone | Approved Investigational Vet Approved | B4GALT1 | 2683 |
downregulated | Dexamethasone results in decreased expression of B4GALT1 mRNA | 9p21.1 | |
| Dexamethasone | Approved Investigational Vet Approved | BAG6 | 7917 |
downregulated | Dexamethasone results in decreased expression of BAG6 mRNA | 6p21.33 | |
| Dexamethasone | Approved Investigational Vet Approved | BAK1 | 578 |
upregulated | Dexamethasone results in increased expression of BAK1 mRNA | 6p21.31 | |
| Dexamethasone | Approved Investigational Vet Approved | BBC3 | 27113 |
downregulated | Dexamethasone results in decreased expression of BBC3 mRNA | 19q13.32 | |
| Dexamethasone | Approved Investigational Vet Approved | BCL2L1 | 598 |
upregulated | Dexamethasone results in increased expression of BCL2L1 mRNA alternative form | 20q11.21 | |
| Dexamethasone | Approved Investigational Vet Approved | BCL2L11 | 10018 |
upregulated | Dexamethasone results in increased expression of BCL2L11 mRNA | 2q13 | |
| Dexamethasone | Approved Investigational Vet Approved | BCL3 | 602 |
downregulated | Dexamethasone results in decreased expression of BCL3 mRNA | 19q13.32 | |